Page last updated: 2024-08-16

tibolone and Coronary Disease

tibolone has been researched along with Coronary Disease in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ameye, L; Antoine, C; de Azambuja, E; Paesmans, M; Rozenberg, S	1
Campisi, R; Marengo, FD	1
Barnes, JF; Farish, E; Fletcher, CD; Hart, DM; Rolton, HA; Spowart, K	1
Moore, RA	1
Anthony, MS; Clarkson, TB; Wagner, JD	1

Reviews

2 review(s) available for tibolone and Coronary Disease

Article	Year
Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovascular drug reviews, 2007,Summer, Volume: 25, Issue:2 Topics: Animals; Atherosclerosis; Blood Coagulation; Cardiovascular System; Coronary Disease; Estrogen Receptor Modulators; Female; Humans; Menopause; Middle Aged; Norpregnenes; Tunica Intima	2007
Livial: a review of clinical studies. British journal of obstetrics and gynaecology, 1999, Volume: 106 Suppl 19 Topics: Affective Symptoms; Anabolic Agents; Bone Diseases; Breast Neoplasms; Climacteric; Coronary Disease; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Libido; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Vaginal Diseases	1999

Trials

1 trial(s) available for tibolone and Coronary Disease

Article	Year
Menopausal hormone therapy use in 17 European countries during the last decade. Maturitas, 2014, Volume: 79, Issue:3 Topics: Aged; Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Europe; Female; Global Health; Humans; Menopause; Middle Aged; Norpregnenes; Progestins; Pulmonary Embolism; Risk Factors; Stroke	2014

Other Studies

2 other study(ies) available for tibolone and Coronary Disease

Article	Year
Effects of tibolone on lipoprotein(a) and HDL subfractions. Maturitas, 1994, Volume: 20, Issue:2-3 Topics: Adult; Aged; Anabolic Agents; Cholesterol, HDL; Cholesterol, VLDL; Climacteric; Coronary Disease; Female; Humans; Lipoprotein(a); Middle Aged; Norpregnenes; Triglycerides	1994
A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:11 Topics: Animals; Antineoplastic Agents, Hormonal; Apolipoproteins; Arteriosclerosis; Body Weight; Bone Density; Cholesterol, HDL; Coronary Disease; Estradiol; Estrogens; Estrone; Female; Horses; Lipoproteins; Macaca fascicularis; Medroxyprogesterone; Norpregnenes; Postmenopause; Progesterone Congeners	2001

Article

Year

Effects of tibolone on lipoprotein(a) and HDL subfractions.

Maturitas, 1994, Volume: 20, Issue:2-3

Topics: Adult; Aged; Anabolic Agents; Cholesterol, HDL; Cholesterol, VLDL; Climacteric; Coronary Disease; Female; Humans; Lipoprotein(a); Middle Aged; Norpregnenes; Triglycerides

1994

A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys.

The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:11

Topics: Animals; Antineoplastic Agents, Hormonal; Apolipoproteins; Arteriosclerosis; Body Weight; Bone Density; Cholesterol, HDL; Coronary Disease; Estradiol; Estrogens; Estrone; Female; Horses; Lipoproteins; Macaca fascicularis; Medroxyprogesterone; Norpregnenes; Postmenopause; Progesterone Congeners

2001